Wellgistics Health FY 2025 net loss widens to USD 101.3 million as net revenues rise 28.7% to USD 23.3 million

Reuters03-21
Wellgistics Health FY 2025 net loss widens to USD 101.3 million as net revenues rise 28.7% to USD 23.3 million
  • Wellgistics Health published an annual report on Form 10-K with full-year results.
  • Net revenues rose 28.73% to USD 23.34 million, while cost of revenues climbed 81.92% to USD 29.76 million, as the year included a full 12 months of post-acquisition activity and was impacted by liquidity constraints and an approximately USD 6.0 million aged-inventory write-off.
  • Gross profit was a loss of USD 6.43 million and net loss was USD 101.27 million.
  • General and administrative expense was USD 70.33 million, including USD 54.79 million of non-cash stock-based compensation, and the company recorded a USD 12.55 million non-cash goodwill and intangible asset impairment charge.
  • Net cash used in operating activities was USD 10.86 million and management said it expects gross margin to improve as liquidity stabilizes and inventory purchasing normalizes in upcoming years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-012004), on March 20, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment